Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review.
about
Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity.A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.UGT1A1*28 relationship with abnormal total bilirubin levels in chronic hepatitis C patients: Outcomes from a case-control study.The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug-drug interactionsHigh prevalence of the UGT1A1*28 variant in HIV-infected individuals in GreeceUGT1A1 (TA)n promoter genotype: Diagnostic and population pharmacogenetic marker in Serbia
P2860
Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Effect of the UGT1A1*28 allele ...... azanavir: a systematic review.
@en
type
label
Effect of the UGT1A1*28 allele ...... azanavir: a systematic review.
@en
prefLabel
Effect of the UGT1A1*28 allele ...... azanavir: a systematic review.
@en
P2093
P2860
P356
P1476
Effect of the UGT1A1*28 allele ...... azanavir: a systematic review.
@en
P2093
Celia L Culley
Mary H H Ensom
Samuel E Gilchrist
Tony K L Kiang
P2860
P304
P356
10.1345/APH.1R550
P407
P577
2013-04-02T00:00:00Z